Scribe Therapeutics Inc. SCTX
16.86 USD -0.50 (-2.88%)
At closeNov 11, 2026, 4:00 PM EST
16.63 -0.23 -1.36%
After hours · Nov 11, 4:00 PM ET
16.70 Day range 17.76
13.50 52-week range 39.60
- YTD
- -11.12%
- 1 year
- -11.12%
SCTX revenue history
Revenue is income from the company’s ordinary business activities.
51,174,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 51,174,000 | 23,761,000 | 86.68% |
| FY 2024 | 2024-12-31 | 27,413,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-27T06:01:23.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.